CD274 and neoplasm: However, in an independent meta-study for predicting response to anti-PD-1 /PD-L1, spatial biomarkers outperformed more traditional methods of patient stratification (such as gene expression profiling, tumor mutational burden assessment, and PD-L1 IHC) [134, 135].